Literature DB >> 3145895

Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.

H Matsunaga1, Y Kuwahara, K Kusugami, K Morise, K Shimokata.   

Abstract

Natural killer (NK) activity, lymphokine-activated killer (LAK) activity and interferon-gamma (IFN-gamma) producing activity of peripheral blood mononuclear cells (PBMC) and regional lymph node mononuclear cells (LNMC) were studied in 23 previously untreated cases of colorectal cancer. NK and LAK activities were significantly lower in LNMC than in PBMC. Patients showed depressed NK and LAK activities in PBMC. In the Dukes C group, especially, both NK activity and LAK activity decreased compared to control patients. NK and LAK activities of PBMC decreased as the grade of invasion to lymphatic channels progressed. LAK activity positively correlated with NK activity in PBMC. Patients with high LAK activity showed high IFN-gamma production in both controls and Dukes A . B patients. However, in Dukes C patients, no relationship between LAK activity and IFN-gamma production was observed. We conclude that the depressed NK and LAK activities of PBMC reflect the local lymphatic invasion and that IFN-gamma involvement in LAK cell generation is impaired in advanced cancer patients. More fundamental studies should be carried out before clinical trials of adoptive immunotherapy using LAK cells, because LAK activity is not induced sufficiently in advanced cancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145895     DOI: 10.1007/bf02779484

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  25 in total

1.  Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.

Authors:  Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1987-08

2.  Inhibition of murine natural killer cell activity by prostaglandins.

Authors:  M J Brunda; R B Herberman; H T Holden
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

3.  Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparation.

Authors:  P Antonelli; W Stewart; B Dupont
Journal:  Clin Immunol Immunopathol       Date:  1981-05

4.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

5.  Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.

Authors:  H F Pross; M G Baines
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

6.  Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression.

Authors:  M Takasugi; A Ramseyer; J Takasugi
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

7.  Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.

Authors:  F Koba; T Akiyoshi; S Arinaga; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1987-03

8.  [Interferon production in vitro].

Authors:  R Kaise; F Hirota; K Sakamoto; M Suminaga; S Sato; M Karibe; K Nagai; H Mugitani; M Kako; H Furue
Journal:  Gan To Kagaku Ryoho       Date:  1987-03

9.  Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.

Authors:  T Abo; C A Miller; G L Gartland; C M Balch
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  3 in total

1.  Impaired regulation of natural killer cells in immunoglobulin synthesis by peripheral blood mononuclear cells from patients with ulcerative colitis.

Authors:  T Kawase; K Kusugami; H Matsunaga; T Matsuura; K Morise
Journal:  Gastroenterol Jpn       Date:  1990-10

2.  Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer.

Authors:  H O Klein; G Golbach; P Voigt; C Coerper; C Bernhardt
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Interleukin 2 and interferon-gamma activities of mononuclear cells from regional lymph nodes in patients with gastric cancer.

Authors:  K Kusugami; T Matsuura; T Kawase; K Ina; H Matsunaga; Y Kuwahara; T Inagaki; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1990-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.